A detailed history of Jupiter Asset Management LTD transactions in Novavax Inc stock. As of the latest transaction made, Jupiter Asset Management LTD holds 100,608 shares of NVAX stock, worth $701,237. This represents 0.01% of its overall portfolio holdings.

Number of Shares
100,608
Previous 880,410 88.57%
Holding current value
$701,237
Previous $5.55 Million 84.28%
% of portfolio
0.01%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

SELL
$6.56 - $9.71 $5.12 Million - $7.57 Million
-779,802 Reduced 88.57%
100,608 $872,000
Q2 2025

Aug 08, 2025

BUY
$5.43 - $7.74 $3.16 Million - $4.51 Million
582,858 Added 195.88%
880,410 $5.55 Million
Q1 2025

May 09, 2025

BUY
$6.41 - $10.82 $1.91 Million - $3.22 Million
297,552 New
297,552 $1.91 Million
Q4 2022

Feb 10, 2023

BUY
$8.86 - $25.04 $324,869 - $918,141
36,667 New
36,667 $376,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $545M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Jupiter Asset Management LTD Portfolio

Follow Jupiter Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jupiter Asset Management LTD with notifications on news.